Overview of novel restore and target treatment approach to classical Hodgkin lymphoma
Application of molecular genetic testing in AML
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?
Improving the assessment of response in relapsed MM
The role of proteasome inhibitors in multiple myeloma